|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61P 35/00 | (2006.01) |
| C07D 239/22 | (2006.01) | ||
| A61K 31/513 | (2006.01) |
| (11) | Number of the document | 3137169 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15785884.6 |
| Date of filing the European patent application | 2015-04-30 | |
| (97) | Date of publication of the European application | 2017-03-08 |
| (45) | Date of publication and mention of the grant of the patent | 2021-11-10 |
| (46) | Date of publication of the claims translation | 2022-04-11 |
| (86) | Number | PCT/US2015/028635 |
| Date | 2015-04-30 |
| (87) | Number | WO 2015/168466 |
| Date | 2015-11-05 |
| (30) | Number | Date | Country code |
| 201461987354 P | 2014-05-01 | US |
| (72) |
CHEN, Young, K. , US
KANOUNI, Toufike , US
KALDOR, Stephen W. , US
STAFFORD, Jeffrey Alan , US
VEAL, James, Marvin , US
|
| (73) |
Celgene Quanticel Research, Inc. ,
9393 Towne Centre Drive, Suite 110, San Diego, CA 92121,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Lizinui specifinės demetilazės-1 inhibitoriai |
| INHIBITORS OF LYSINE SPECIFIC DEMETHYLASE-1 |
| Payment date | Validity (years) | Amount | |
| 2024-04-11 | 10 | 231.00 EUR |
| 2025-04-30 |